Advertisement

GI & Endoscopy

Vision-Sciences, a flexible endoscopic products company headquarters in Orangeburg, N.Y., has announced $4.2 million in fourth quarter revenue for the 2013 fiscal year, which ended March 31.

At the Experimental Biology 2013 meeting held in Boston April 20 to 24, Entera Health presented nonclinical studies demonstrating oral serum-derived bovine immunoglobulin/protein isolate (SBI) as a promising treatment for irritable bowel syndrome.

Advertisement

Michael Gluck, MD, board certified in internal medicine and gastroenterology, has been named the chief of medicine at Virginia Mason Medical Center in Seattle, according to a report by The Seattle Times.

Here are 11 statistics on gastroenterologist thoughts about accountable care organizations and where they are heading in the future from Medscape Physician Compensation Report 2012.

Advertisement